Advertisement
UK markets closed
  • FTSE 100

    8,239.99
    +68.87 (+0.84%)
     
  • FTSE 250

    20,589.29
    +59.87 (+0.29%)
     
  • AIM

    770.10
    -0.02 (-0.00%)
     
  • GBP/EUR

    1.1803
    -0.0007 (-0.06%)
     
  • GBP/USD

    1.2765
    +0.0018 (+0.14%)
     
  • Bitcoin GBP

    45,245.13
    -1,928.89 (-4.09%)
     
  • CMC Crypto 200

    1,201.64
    -59.55 (-4.72%)
     
  • S&P 500

    5,537.02
    +28.01 (+0.51%)
     
  • DOW

    39,308.00
    -23.90 (-0.06%)
     
  • CRUDE OIL

    83.91
    +0.03 (+0.04%)
     
  • GOLD FUTURES

    2,369.40
    0.00 (0.00%)
     
  • NIKKEI 225

    40,913.65
    +332.89 (+0.82%)
     
  • HANG SENG

    18,028.28
    +49.71 (+0.28%)
     
  • DAX

    18,453.24
    +78.71 (+0.43%)
     
  • CAC 40

    7,695.10
    +63.02 (+0.83%)
     

Dawnrays Pharmaceutical Holdings And Two Other High Yield Dividend Stocks In Hong Kong

Amid a backdrop of fluctuating global markets, with the Hang Seng Index recently experiencing a notable decline, investors are increasingly focused on stable income streams. In this context, high-yield dividend stocks in Hong Kong, such as Dawnrays Pharmaceutical Holdings, offer potential for both income and diversification in uncertain times.

Top 10 Dividend Stocks In Hong Kong

Name

Dividend Yield

Dividend Rating

China Construction Bank (SEHK:939)

7.70%

★★★★★★

Chongqing Rural Commercial Bank (SEHK:3618)

8.75%

★★★★★★

CITIC Telecom International Holdings (SEHK:1883)

9.81%

★★★★★★

Consun Pharmaceutical Group (SEHK:1681)

9.00%

★★★★★☆

S.A.S. Dragon Holdings (SEHK:1184)

9.07%

★★★★★☆

Playmates Toys (SEHK:869)

8.57%

★★★★★☆

Bank of China (SEHK:3988)

6.86%

★★★★★☆

China Mobile (SEHK:941)

6.29%

★★★★★☆

Sinopharm Group (SEHK:1099)

4.13%

★★★★★☆

International Housewares Retail (SEHK:1373)

8.62%

★★★★★☆

Click here to see the full list of 89 stocks from our Top Dividend Stocks screener.

ADVERTISEMENT

Let's explore several standout options from the results in the screener.

Dawnrays Pharmaceutical (Holdings)

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: Dawnrays Pharmaceutical (Holdings) Limited is an investment holding company that focuses on the development, manufacture, and sale of non-patented pharmaceutical medicines in Mainland China and internationally, with a market capitalization of approximately HK$1.79 billion.

Operations: Dawnrays Pharmaceutical (Holdings) Limited generates revenue primarily through the sale of finished drugs, which brought in CN¥1.02 billion, and intermediates and bulk medicines, contributing CN¥210.05 million.

Dividend Yield: 6.7%

Dawnrays Pharmaceutical recently approved a final dividend of HK$0.065 per share for 2023, reflecting a decrease from the previous year's HK$0.073. Despite this reduction, the company maintains a sustainable dividend with a payout ratio of 33.4% and is adequately covered by earnings and cash flows (cash payout ratio of 87.6%). However, its historical dividend track record has been unstable, showing volatility over the past decade which might concern conservative dividend investors seeking reliability in payouts.

SEHK:2348 Dividend History as at Jun 2024
SEHK:2348 Dividend History as at Jun 2024

Eagle Nice (International) Holdings

Simply Wall St Dividend Rating: ★★★★★☆

Overview: Eagle Nice (International) Holdings Limited is an investment holding company that manufactures and trades sportswear and garments across Mainland China, the United States, Europe, Japan, and other international markets, with a market capitalization of approximately HK$2.60 billion.

Operations: Eagle Nice (International) Holdings Limited generates revenue primarily from sportswear and garment sales, with HK$2.24 billion from Mainland China, HK$757.55 million from the USA, HK$466.21 million from Europe, and HK$87.67 million from Japan.

Dividend Yield: 7.8%

Eagle Nice (International) Holdings has demonstrated a mixed dividend history with a 10-year period of volatility, including significant annual drops. Despite this, its current dividend yield of 7.79% ranks in the top quartile for Hong Kong, supported by a cash payout ratio of 44.5% and an earnings payout ratio of 71.7%. Recent board changes could influence future financial strategies, potentially impacting dividend reliability and growth prospects.

SEHK:2368 Dividend History as at Jun 2024
SEHK:2368 Dividend History as at Jun 2024

Zhongsheng Group Holdings

Simply Wall St Dividend Rating: ★★★★☆☆

Overview: Zhongsheng Group Holdings Limited operates as an investment holding company, focusing on the sale and service of motor vehicles in the People’s Republic of China, with a market capitalization of approximately HK$37.31 billion.

Operations: Zhongsheng Group Holdings Limited generates revenue primarily through the sale of motor vehicles and related services, totaling approximately CN¥179.29 billion.

Dividend Yield: 5.1%

Zhongsheng Group Holdings, despite a recent dividend decrease to HK$0.797 per share, maintains a sustainable payout with an earnings coverage of 35.2% and cash flow coverage of 49.7%. The firm's sales slightly declined from CNY 179.86 billion to CNY 179.29 billion year-over-year, with net income also falling from CNY 6.69 billion to CNY 5.02 billion. Recent executive appointments suggest potential strategic shifts, possibly impacting future financial management and dividend policies.

SEHK:881 Dividend History as at Jun 2024
SEHK:881 Dividend History as at Jun 2024

Seize The Opportunity

  • Gain an insight into the universe of 89 Top Dividend Stocks by clicking here.

  • Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.

  • Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.

Interested In Other Possibilities?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include SEHK:2348 SEHK:2368 and SEHK:881.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com